Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9149464 Bendamustine derivatives and methods of using same

Patent 9149464 was granted and assigned to Ignyta, Inc. on October, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9149464

Date of Patent

October 6, 2015

Patent Application Number

14711747

Date Filed

May 13, 2015

Patent Citations Received

‌

US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors

‌

US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

‌

US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

Patent Primary Examiner

‌

Laura L. Stockton

Patent abstract

The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9149464 Bendamustine derivatives and methods of using same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API